Showing results (91-100 of 189) with videos related to

Sort By:
Pageof 19
Journal of Clinical Microbiology|May 1, 2002
Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancerSpencer W Redding, William R Kirkpatrick, Brent J Coco, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2015
Efficacy of the investigational echinocandin ASP9726 in a guinea pig model of invasive pulmonary aspergillosisNathan P Wiederhold, Laura K Najvar, Satoru Matsumoto, et al.
Medical Mycology|March 17, 2007
Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipientSteven D Westbrook, William R Kirkpatrick, Cesar O Freytes, et al.
Journal of Clinical Pathology|November 4, 2011
Antifungal treatment affects the laboratory diagnosis of invasive aspergillosisElaine McCulloch, Gordon Ramage, Ranjith Rajendran, et al.
Experimental Parasitology|February 23, 2011
Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replicationMichael J Brumlik, Standwell Nkhoma, Mark J Kious, et al.
Open Forum Infectious Diseases|August 6, 2020
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19George R Thompson Iii, Oliver A Cornely, Peter G Pappas, et al.
Virulence|June 9, 2016
Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungiNathan P Wiederhold, Thomas F Patterson, Anand Srinivasan, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2017
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trialDimitrios P Kontoyiannis, Dominik Selleslag, Kathleen Mullane, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2024
Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin BTeclegiorgis Gebremariam, Sondus Alkhazraji, Yiyou Gu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2014
Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases GroupRaoul Herbrecht, Thomas F Patterson, Monica A Slavin, et al.
Pageof 19